QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 281 filers reported holding QIAGEN NV in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229 | -9.8% | 5,640 | -0.1% | 0.01% | -8.3% |
| Q2 2023 | $254 | -7.6% | 5,644 | -6.6% | 0.01% | -7.7% |
| Q1 2023 | $275 | -15.9% | 6,041 | -7.1% | 0.01% | -23.5% |
| Q4 2022 | $327 | -100.0% | 6,505 | -59.2% | 0.02% | -55.3% |
| Q3 2022 | $671,000 | -39.2% | 15,948 | -32.5% | 0.04% | -33.3% |
| Q2 2022 | $1,104,000 | +53.5% | 23,620 | +62.5% | 0.06% | +83.9% |
| Q1 2022 | $719,000 | -11.1% | 14,531 | 0.0% | 0.03% | -3.1% |
| Q4 2021 | $809,000 | +1.9% | 14,531 | -4.9% | 0.03% | -5.9% |
| Q3 2021 | $794,000 | +11.7% | 15,279 | +3.8% | 0.03% | +6.2% |
| Q2 2021 | $711,000 | +308.6% | 14,713 | +309.8% | 0.03% | +255.6% |
| Q1 2021 | $174,000 | -34.3% | 3,590 | -29.7% | 0.01% | -40.0% |
| Q4 2020 | $265,000 | -20.7% | 5,109 | -20.6% | 0.02% | -28.6% |
| Q3 2020 | $334,000 | +115.5% | 6,437 | +79.3% | 0.02% | +90.9% |
| Q2 2020 | $155,000 | +7.6% | 3,590 | 0.0% | 0.01% | -8.3% |
| Q1 2020 | $144,000 | -80.6% | 3,590 | -83.5% | 0.01% | -76.5% |
| Q4 2019 | $743,000 | – | 21,712 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |